{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:02:51Z","timestamp":1777636971905,"version":"3.51.4"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coxsackievirus A5 (CVA5) is an emerging pathogen associated with severe hand, foot, and mouth disease. Protective antibodies are critical for protection from CVA5 infection, yet the antigenic determinants of CVA5 remain poorly defined. In this study, we aimed to map the conformational neutralizing epitopes of CVA5 using monoclonal antibodies (mAbs) and escape mutant analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Two IgG, one IgA, and five IgM neutralizing mAbs were purified and characterized for binding affinity and neutralization potency. Antibody pressure selection was applied to generate immune escape mutants, and comparative sequence analysis with wild-type virus identified potential critical residues. Reverse genetics was used to confirm key sites pivotal for mAb recognition. Structural mapping was performed to localize these sites on the viral capsid.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ten key sites (K1103, V1215, N1282, F1288, T1291, K2076, E2160, T3059, D3060, E3139) were confirmed to be pivotal for mAb recognition. Structural mapping revealed distinct localization of these sites on the viral capsid: V1215, N1282, F1288, T1291, K2076, E2160, T3059, D3060 at the southern rim; K1103 at the canyon\u2019s northern rim; and E3139 near the two-fold axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides the first evidence of multiple conformational neutralizing epitopes on CVA5. These findings define the antigenic basis of CVA5 neutralization and offer a structural framework for vaccine and antibody-based therapeutic development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1837533","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:59:24Z","timestamp":1777442364000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of key amino acids defining conformational neutralizing epitopes of coxsackievirus A5 using monoclonal antibody escape mutants"],"prefix":"10.3389","volume":"17","author":[{"given":"Ke","family":"Xu","sequence":"first","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"Vaccine Technology Innovation Center of Hubei Province","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Pei","sequence":"additional","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"Vaccine Technology Innovation Center of Hubei Province","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"Vaccine Technology Innovation Center of Hubei Province","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"Vaccine Technology Innovation Center of Hubei Province","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Qi","family":"Chen","sequence":"additional","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"Vaccine Technology Innovation Center of Hubei Province","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Shen","sequence":"additional","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"Vaccine Technology Innovation Center of Hubei Province","place":["Wuhan, Hubei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-8-297","article-title":"Epidemics of enterovirus infection in Chungnam Korea, 2008 and 2009","volume":"8","author":"Baek","year":"2011","journal-title":"Virol J"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms14020329","article-title":"Genetic diversity and excretion kinetics of enteroviruses excreted by patients with primary immunodeficiency in Tunisia over a five-year period (2020-2024)","volume":"14","author":"Ben Salem","year":"2026","journal-title":"Microorganisms"},{"key":"B3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s44197-025-00477-9","article-title":"Preliminary genetic characterization of enteroviruses in pediatric HFMD cases: First data from Jeddah, Saudi Arabia","volume":"15","author":"Alsulami","year":"2025","journal-title":"J Epidemiol Glob Health"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29827","article-title":"Molecular epidemiology and characterization of enteroviruses detected in cerebrospinal fluid and respiratory samples in Slovenia, 2014-2023","volume":"96","author":"Berginc","year":"2024","journal-title":"J Med Virol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"20909","DOI":"10.1038\/s41598-020-77768-7","article-title":"Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China","volume":"10","author":"Meng","year":"2020","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12920-021-01107-6","article-title":"Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China","volume":"14","author":"Yu","year":"2021","journal-title":"BMC Med Genomics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00007-11","article-title":"Complete genome analysis of coxsackievirus A2, A4, A5, and A10 strains isolated from hand, foot, and mouth disease patients in China revealing frequent recombination of human enterovirus A","volume":"49","author":"Hu","year":"2011","journal-title":"J Clin Microbiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01743-20","article-title":"Efficacy of coxsackievirus A5 vaccine candidates in an actively immunized mouse model","volume":"95","author":"Jin","year":"2021","journal-title":"J Virol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41467-017-00736-9","article-title":"Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children","volume":"8","author":"Huang","year":"2017","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1038\/s41467-020-18250-w","article-title":"Serotype specific epitopes identified by neutralizing antibodies underpin immunogenic differences in Enterovirus B","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0275-7","article-title":"Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization","volume":"4","author":"Zheng","year":"2019","journal-title":"Nat Microbiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01013-18","article-title":"Neutralization mechanisms of two highly potent antibodies against human enterovirus 71","volume":"9","author":"Zhu","year":"2018","journal-title":"mBio"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02189-15","article-title":"Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry","volume":"89","author":"Ku","year":"2015","journal-title":"J Virol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1524356","article-title":"Neutralizing antibody landscape of the non-polio enteroviruses and future strategy","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.02.051","article-title":"Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16","volume":"31","author":"Shi","year":"2013","journal-title":"Vaccine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1565266","article-title":"A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge","volume":"15","author":"Du","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"B17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12985-024-02596-4","article-title":"Discovery of a broad-spectrum monoclonal antibody recognizing a conserved, linear epitope WFYDGYPT on VP1 protein of Enterovirus A species","volume":"21","author":"Fu","year":"2024","journal-title":"Virol J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/v15041028","article-title":"Identification of a conserved, linear epitope on VP3 of enterovirus A species recognized by a broad-spectrum monoclonal antibody","volume":"15","author":"Fu","year":"2023","journal-title":"Viruses"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.02.037","article-title":"Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera","volume":"184","author":"Zhou","year":"2021","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s42003-024-06406-z","article-title":"An immobilized antibody-based affinity grid strategy for on-grid purification of target proteins enables high-resolution cryo-EM","volume":"7","author":"Zhao","year":"2024","journal-title":"Commun Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0286-4","article-title":"Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein","volume":"4","author":"Kim","year":"2019","journal-title":"Nat Microbiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41467-025-55871-5","article-title":"Reverse mutational scanning of SARS-CoV-2 spike BA.2.86 identifies epitopes contributing to immune escape from polyclonal sera","volume":"16","author":"Bdeir","year":"2025","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2025.103002","article-title":"Bias in, bias out -AlphaFold-Multimer and the structural complexity of protein interfaces","volume":"91","author":"Strom","year":"2025","journal-title":"Curr Opin Struct Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.25802","article-title":"RMSD and symmetry","volume":"40","author":"Coutsias","year":"2019","journal-title":"J Comput Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-588-6_10","article-title":"Methods of protein structure comparison","volume":"857","author":"Kufareva","year":"2012","journal-title":"Methods Mol Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aat7459","article-title":"Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10","volume":"4","author":"Zhu","year":"2018","journal-title":"Sci Adv"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1320624111","article-title":"Neutralizing antibodies can initiate genome release from human enterovirus 71","volume":"111","author":"Plevka","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.01.003","article-title":"Identification of antibodies with bon-overlapping neutralization sites that target coxsackievirus A16","volume":"27","author":"He","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7854","DOI":"10.1038\/s41467-022-35575-w","article-title":"Molecular mechanism of antibody neutralization of coxsackievirus A16","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005454","article-title":"Structural basis for recognition of human enterovirus 71 by a bivalent broadly neutralizing monoclonal antibody","volume":"12","author":"Ye","year":"2016","journal-title":"PloS Pathog"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.03.019","article-title":"KREMEN1 is a host entry receptor for a major group of enteroviruses","volume":"23","author":"Staring","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005341117","article-title":"Molecular basis of coxsackievirus A10 entry using the two-in-one attachment and uncoating receptor KRM1","volume":"117","author":"Cui","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1038\/s41467-018-07531-0","article-title":"Structures of Coxsackievirus A10 unveil the molecular mechanisms of receptor binding and viral uncoating","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9302","article-title":"Prospective mapping of viral mutations that escape antibodies used to treat COVID-19","volume":"371","author":"Starr","year":"2021","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1038\/s41467-023-37826-w","article-title":"Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy","volume":"14","author":"Ragonnet-Cronin","year":"2023","journal-title":"Nat Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1837533\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:59:25Z","timestamp":1777442365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1837533\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2026.1837533"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1837533","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"article-number":"1837533"}}